A key finding in the report was that several multinational firms had launched drugs without conducting mandatory clinical trials or seeking expert medical opinion The health ministry has denied the presence of any systemic rot in the drug approval process and pharmaceutical firms have refuted charges of collusion after a report by a parliamentary panel pointed to regulatory lapses in clinical trials. The panel, which looked into the functioning of Central Drugs...
More »SEARCH RESULT
Total Matching Records found : 2911
Supreme Court should halt undermining of the purpose of setting up an SIT
-The Economic Times The Supreme Court-appointed Special Investigation Team (SIT) has concluded in its final report that it would not amount to an offence even if Gujarat chief ministerNarendra Modi hypothetically did say something about 'allowing Hindus to vent their anger' in a meeting with top police officers after the Godhra carnage in 2002. That is an appalling conclusion. If Modi did actually make that statement, it patently cannot be called...
More »Gujarat riots: 'So what if words were spoken within 4 walls?'
-Express News Service The Supreme Court appointed Special Investigation Team (SIT) has concluded that even if Narendra Modi gave an illegal verbal instruction to allow Hindus to “vent their anger” after the Godhra carnage, it was not an offence. “...The interpretations made on alleged illegal instructions given by the Chief Minister by (police officers) Shri R B Sreekumar and Shri Sanjiv Bhatt, appear to be without any basis. Further, even if such...
More »SIT rejects amicus curiae's observations against Modi-Manas Dasgupta
It dismisses as “false and fabricated documents” fax messages claimed to have been sent by Sanjiv Bhatt The Supreme Court-appointed Special Investigation Team has totally disagreed with the observations of amicus curiae Raju Ramachandran, and said no case can be made out against Gujarat Chief Minister Narendra Modi in connection with the 2002 communal riots under any of the Sections of the Indian Penal Code mentioned by him. Mr. Ramachandran, in his...
More »Panel exposes flaws in India’s drug approval procedure-Vidya Krishnan
A report by a parliamentary committee has shown that the drug industry regulator, the Drug Controller General of India (DCGI), has been approving, on average, one new drug a month without conducting mandatory clinical trials or seeking expert medical opinion—findings that expose the deep flaws prevalent in India’s drug approval process. The committee has asked the health ministry to withdraw the discretionary powers given to the Central Drugs Standard Control Organization...
More »
